HomeKHRNF • OTCMKTS
add
Khiron Life Sciences Corp
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2022info | Y/Y change |
|---|---|---|
Revenue | 3.38M | — |
Operating expense | 5.16M | — |
Net income | -3.58M | — |
Net profit margin | -105.64 | — |
Earnings per share | -0.02 | — |
EBITDA | -3.16M | — |
Effective tax rate | -3.62% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.94M | — |
Total assets | 38.45M | — |
Total liabilities | 11.35M | — |
Total equity | 27.10M | — |
Shares outstanding | 216.39M | — |
Price to book | 0.00 | — |
Return on assets | -22.27% | — |
Return on capital | -28.32% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2022info | Y/Y change |
|---|---|---|
Net income | -3.58M | — |
Cash from operations | -5.04M | — |
Cash from investing | -872.00K | — |
Cash from financing | 864.00K | — |
Net change in cash | -3.88M | — |
Free cash flow | -1.78M | — |
About
Founded
May 16, 2012
Headquarters
Website
Employees
310
